Latest Memorial Sloan–Kettering Cancer Center Stories
There is new hope for people with acute myelogenous leukemia (AML), a fast-growing cancer of the blood and bone marrow.
Because primary lung adenocarcinoma is exceedingly rare in the pediatric population, it is difficult to properly classify certain lung tumors in children and adolescents.
An international study led by researchers at Memorial Sloan-Kettering Cancer Center has identified genetic variants in women with BRCA2 mutations that may increase or decrease their risk of developing breast cancer.
Minority patients have a significantly decreased survival from colon cancer compared to white patients, most often as a result of a late diagnosis.
HACKENSACK, N.J., Oct.
NEW YORK, Oct. 19 /PRNewswire/ -- The largest donation in the Lung Cancer Research Foundation's (LCRF, www.lungfund.org) history was announced in New York today by LCRF founder Laurie C. Carson. In announcing the 2.1 million dollar donation, Ms.
A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies.
NEW YORK, Sept. 27 /PRNewswire-USNewswire/ -- The T.J. Martell Foundation for Leukemia, Cancer and AIDS Research will honor several leaders at its 35th Annual Awards Gala on Wednesday, October 27th, 2010 at the Marriott Marquis Times Square in Manhattan.
A blood test at the age of 60 can accurately predict the risk that a man will die from prostate cancer within the next 25 years.
A team of scientists, led by University of California, San Diego School of Medicine researchers, has synthesized hundreds of new compounds with the potential of reducing the production of the A-beta 42 peptide, a primary component of Alzheimer's disease (AD).
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.